Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Barramundi (BRM) / FY23

NTA per share rose 12.5% to $0.72 as portfolio swung to $43.6m total return

Investment income covered only 40.7% of distributions paid, so capital recycling continues to fund shareholder payouts despite the headline profit

Investment Companies / Listed investment company

NTA/NAV per share

Net tangible asset or net asset value per share, shown in per-share cents for chart readability.

↗
Loading chart...
  • HY22 BRM: Unprecedented high nta/nav per share. 0.85x; 4-period range 0.63x to 0.75x. NTA/NAV per share: 0.85x, unprecedented high; 4-period mean 0.69x, range 0.63x-0.75x.
  • FY22 BRM: Outside range low nta/nav per share. 0.64x; 4-period range 0.72x to 30x. NTA/NAV per share: 0.64x, below normal range; 4-period mean 8.09x, range 0.72x-30.00x.
  • FY25 BRM: Unprecedented high nta/nav per share. 30x; 4-period range 0.64x to 0.87x. NTA/NAV per share: 30.00x, unprecedented high; 4-period mean 0.75x, range 0.64x-0.87x.
  • HY26 BRM: Outside range low nta/nav per share. 0.63x; 4-period range 0.65x to 0.85x. NTA/NAV per share: 0.63x, below normal range; 4-period mean 0.75x, range 0.65x-0.85x.
NTA/NAV per share: 0.63x, below normal range; 4-period mean 0.75x, range 0.65x-0.85x.

Investment income

Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.

↗
Loading chart...
  • FY21 BRM: Unprecedented low investment income. $2.9m; 4-period range $3.8m to $4.8m. Investment income: NZ$2.9m, unprecedented low; 4-period mean NZ$4.2m, range NZ$3.8m-NZ$4.8m.
  • HY22 BRM: Outside range low investment income. $1.9m; 4-period range $2m to $2.4m. Investment income: NZ$1.9m, below normal range; 4-period mean NZ$2.2m, range NZ$2.0m-NZ$2.4m.
  • FY25 BRM: Unprecedented high investment income. $4.8m; 4-period range $2.9m to $4.2m. Investment income: NZ$4.8m, unprecedented high; 4-period mean NZ$3.7m, range NZ$2.9m-NZ$4.2m.
  • HY26 BRM: Outside range high investment income. $2.4m; 4-period range $1.9m to $2.4m. Investment income: NZ$2.4m, above normal range; 4-period mean NZ$2.1m, range NZ$1.9m-NZ$2.4m.
Investment income: NZ$2.4m, above normal range; 4-period mean NZ$2.1m, range NZ$1.9m-NZ$2.4m.

Investment total return

Total income or return including fair-value or capital movement where disclosed.

↗
Loading chart...
  • FY21 BRM: Outside range high investment total return. $57.2m; 4-period range $-32.6m to $43.6m. Investment total return: NZ$57.2m, above normal range; 4-period mean NZ$14.1m, range NZ$-32.6m-NZ$43.6m.
  • FY22 BRM: Unprecedented low investment total return. $-32.6m; 4-period range $12.5m to $57.2m. Investment total return: NZ$-32.6m, unprecedented low; 4-period mean NZ$36.6m, range NZ$12.5m-NZ$57.2m.
  • HY24 BRM: Outside range high investment total return. $19.7m; 4-period range $-13.5m to $17.3m. Investment total return: NZ$19.7m, above normal range; 4-period mean NZ$8.3m, range NZ$-13.5m-NZ$17.3m.
  • HY26 BRM: Unprecedented low investment total return. $-13.5m; 4-period range $14.3m to $19.7m. Investment total return: NZ$-13.5m, unprecedented low; 4-period mean NZ$16.6m, range NZ$14.3m-NZ$19.7m.
Investment total return: NZ$-13.5m, unprecedented low; 4-period mean NZ$16.6m, range NZ$14.3m-NZ$19.7m.

Net assets attributable

Net asset base attributable to shareholders or unitholders.

↗
Loading chart...
  • FY22 BRM: Outside range low net assets attributable. $170.7m; 4-period range $185.7m to $240.6m. Net assets attributable: NZ$170.7m, below normal range; 4-period mean NZ$210.4m, range NZ$185.7m-NZ$240.6m.
  • HY23 BRM: Unprecedented low net assets attributable. $178.1m; 4-period range $211.1m to $248.3m. Net assets attributable: NZ$178.1m, unprecedented low; 4-period mean NZ$226.0m, range NZ$211.1m-NZ$248.3m.
  • HY25 BRM: Unprecedented high net assets attributable. $248.3m; 4-period range $178.1m to $225.9m. Net assets attributable: NZ$248.3m, unprecedented high; 4-period mean NZ$208.5m, range NZ$178.1m-NZ$225.9m.
  • FY25 BRM: Unprecedented high net assets attributable. $240.6m; 4-period range $170.7m to $215.9m. Net assets attributable: NZ$240.6m, unprecedented high; 4-period mean NZ$192.9m, range NZ$170.7m-NZ$215.9m.
Net assets attributable: NZ$240.6m, unprecedented high; 4-period mean NZ$192.9m, range NZ$170.7m-NZ$215.9m.
Release date
22 August 2023
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Net profit after tax

$38.3m

+210.7% ↑ vs −$34.6m

Net cash inflow from operating activities

$13.1m

+172.6% ↑ vs −$18m

Full-year dividend per share

2.8c

+105.9% ↑ vs 1.4c

Profit before tax

$39.4m

+211.9% ↑ vs −$35.2m

Cash and cash equivalents

$5.9m

+127.4% ↑ vs $2.6m

Total assets

$201.2m

+16.7% ↑ vs $172.3m

What changed

Net tangible assets per share rose 12.5% to $0.72, and net assets attributable to shareholders grew 16.7% to $199.2m, reflecting a sharp reversal in portfolio fair-value movements after FY22's market sell-off

As noted in the Barramundi 2023 Annual Report, the economic impact of sharply rising interest rates — including moves by the Reserve Bank of Australia — had contributed to a broad market sell-off during 2022. Investment total return swung to +$43.6m from -$32.6m, with reported NPAT moving to +$38.3m from a -$34.6m loss and PBT to +$39.4m from -$35.2m.

Underlying investment income (dividends and interest) was almost flat, growing 5.2% to $4.0m on $3.8m prior. Net cash flow from operating activities turned positive at $13.1m versus -$18.0m, and the cash balance more than doubled to $5.9m. The declared final dividend was 1.44cps (prior final: 1.36cps), with the disclosed full-year distribution at 2.80cps.

What matters

Headline profit is portfolio-mark driven, not income driven

  • The $73.0m NPAT swing is overwhelmingly explained by the $76.2m turnaround in portfolio total return, not by a step change in dividend or interest receipts. For an investment company, the cleaner read is NTA per share growth of 12.5% and net asset growth of 16.7%, which is what shareholders capture through the unit.
  • Distribution coverage from investment income remains structurally low. Investment income of $4.0m covered only 40.7% of the $9.8m distributions paid in the period (FY22: 34.4%). The improvement is real but small, which means the remaining roughly 60% of distributions continues to rely on capital recycling from the portfolio rather than recurring portfolio yield. This matters because in a year of negative portfolio return that mechanism erodes NTA per share rather than just paying out income.
  • Balance sheet expansion is share-issuance and mark-to-market, not gearing. Total liabilities are only $2.0m against total assets of $201.2m. There is no meaningful debt funding the portfolio, so the equity-style ROE of 19.3% (FY22: -20.3%) reflects portfolio direction rather than financial leverage.

Expectations

The release does not include a directly stated portfolio total return percentage or a benchmark comparison that can be cleanly used here, and no forward distribution guidance is disclosed in the supplied data

The result therefore supports a constructive read on FY23 portfolio recovery and NTA rebuild but does not by itself anchor a forward portfolio-return expectation or a benchmark-relative judgement.

What the release does support is that the 2.80cps full-year distribution is being sustained at a coverage level (40.7% from investment income) that depends on continued portfolio realisations to fund the cash payout. A repeat of FY22-style negative total return would re-open the gap between distributions paid and investment income earned.

Quality of result

The investment income line is the most durable part of this result and grew only 5.2%

Everything else of size, including the swing to a $38.3m NPAT, $13.1m operating cash inflow and 16.7% net-asset uplift, is the reversal of FY22's portfolio mark-down rather than a structural change in the portfolio's earning power. That is normal for an investment company, but it means readers should not extrapolate the headline growth rates as a run-rate.

NTA per share growth of 12.5% is the cleanest durable metric in the release, because it nets investment income, fees, distributions and fair-value movement into a single per-share outcome. It is also consistent with a portfolio recovery year rather than a step-up in the underlying portfolio holdings' cash generation. The very low effective tax rate (2.8% current, 1.4% prior) reflects the PIE / investment-company tax treatment of unrealised gains rather than an operating tax tailwind, and should not be read as a margin improvement.

Unresolved

Open questions

What was the portfolio's total return for FY23, and how did it compare to the stated benchmark on a like-for-like basis?
What is the company's view on distribution sustainability given investment income still covers only 40.7% of distributions paid?
How did the largest holdings contribute to or detract from the year's portfolio return, and is concentration rising as a result?
What is the current management expense ratio relative to net assets, and is fee scale moving with the larger asset base?
Is the board signalling any change to distribution policy if portfolio returns normalise lower than FY23?

This briefing cannot assess portfolio-level concentration, the realised-vs-unrealised split of the total return, or relative performance against the benchmark, because those disclosures are not provided in the supplied data.

Chat

Ask about BRM FY23

Ask follow-up questions about Barramundi's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about BRM FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Barramundi's FY23 result.

What was the portfolio's total return for FY23, and how did it compare to the stated benchmark on a like-for-like basis?Why does "Headline profit is portfolio-mark driven, not income driven" matter?How strong was the cash and earnings quality in FY23?What should I watch next for BRM after FY23?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Barramundi Limited 2023 Annual Report

FY23 / financial report↗

Prior comparable period

Barramundi Limited 2022 Annual Report

FY22 / financial report↗

Interim context

BRM - Commentary for the interim period 2023

HY23 / results release↗

BRM - Interim financial statements for period 31 Dec 2022 incl review report

HY23 / financial report↗

BRM - Preliminary half year announcement - 31 Dec 2022

HY23 / results announcement↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 1.6pp, with a distortion flag in the result.

→

ROE and capital efficiency

ROE was 19.3%, +39.6pp versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 19.8%.

→

Revenue growth context

Revenue growth was 5.2% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when BRM publishes next

Get the next Barramundi briefing and related NZX reporting-season updates by email.